10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001437749-22-002626`
Period End Date	20211231
Filing Date	20220207
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	tech20211231_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 96 Income Statement 96 Cash Flow Statement 90

Balance Sheet 96 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.23M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.33M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$211.84M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.09M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$67.14M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$32.46M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,334 and $1,229, respectively	`AccountsReceivableNetCurrent`	$152.90M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,334 and $1,229, respectively	`AccountsReceivableNetCurrent`	$145.38M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$121.86M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$116.75M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$36.50M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.92M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$590.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$510.61M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.96M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$207.91M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	39.32M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$211.81M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	39.32M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$64.29M	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$73.83M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.96M	shares	Point-in-time
Goodwill	`Goodwill`	$843.07M	USD	Point-in-time
Goodwill	`Goodwill`	$843.07M	USD	Point-in-time
Goodwill	`Goodwill`	$832.06M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$615.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$615.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$569.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$37.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.57M	USD	Point-in-time
Total assets	`Assets`	$2.26B	USD	Point-in-time
Total assets	`Assets`	$2.30B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$26.76M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$29.38M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$43.92M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$51.29M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.28M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$19.08M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$19.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$5.34M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$14.28M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.60M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.81M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$4.00M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$2.00M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$5.47M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$152.28M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$154.81M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$93.12M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$101.42M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$328.83M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$269.62M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$25.40M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$7.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$57.72M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.62M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$11.75M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$24.46M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,319,766 and 38,955,484, respectively	`CommonStockValue`	$390.00K	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,319,766 and 38,955,484, respectively	`CommonStockValue`	$393.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$616.43M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$534.41M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.15B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.09B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-59.47M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-57.29M	USD	Point-in-time
Total Bio-Technes shareholders' equity	`StockholdersEquity`	$1.56B	USD	Point-in-time
Total Bio-Technes shareholders' equity	`StockholdersEquity`	$1.70B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-458.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.26M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.44B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.26B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.30B	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$428.45M	USD	2 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$224.25M	USD	1 Quarter
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$527.00M	USD	2 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$269.28M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$73.35M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$85.58M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$139.82M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$172.31M	USD	2 Qtrs
Gross margin	`GrossProfit`	$183.69M	USD	1 Quarter
Gross margin	`GrossProfit`	$288.63M	USD	2 Qtrs
Gross margin	`GrossProfit`	$354.69M	USD	2 Qtrs
Gross margin	`GrossProfit`	$150.90M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$83.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$100.69M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$155.71M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$186.87M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$32.83M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$16.79M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$42.25M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$20.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$121.34M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$188.54M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$229.12M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$99.91M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$100.09M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$62.35M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$125.57M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$50.99M	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$5.37M	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$27.99M	USD	2 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$-4.38M	USD	2 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$23.83M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$86.18M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$95.71M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$56.37M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$153.56M	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$12.52M	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$14.12M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$10.22M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$16.17M	USD	2 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$79.54M	USD	2 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$141.04M	USD	2 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.11M	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-130.00K	USD	2 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-130.00K	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.75M	USD	2 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$80.17M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$149.79M	USD	2 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$46.27M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$79.67M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$16.93M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.92M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-6.72M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$28.84M	USD	2 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$2.06M	USD	1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$2.88M	USD	1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$4.57M	USD	2 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$4.20M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$18.99M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-6.96M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$33.04M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.81M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.16M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$14.06M	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$83.00K	USD	2 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$27.00K	USD	2 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$83.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$66.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.74M	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$18.90M	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$32.96M	USD	2 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.18M	USD	2 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$147.60M	USD	2 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$65.18M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$84.92M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$112.63M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.20	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.06	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.04	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.82	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.64	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.98	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.94	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.15	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.61M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	39.31M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	39.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.69M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.26M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.21M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.16M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.13M	shares	2 Qtrs

Cash Flow Statement 90 line items

Line Item	Tag	Value	Unit	Period
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$79.54M	USD	2 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$141.04M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.97M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$49.84M	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$23.00K	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.60M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$216.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$7.23M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$28.53M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$25.71M	USD	2 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.30M	USD	2 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-155.00K	USD	2 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$4.60M	USD	2 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-16.40M	USD	2 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-33.67M	USD	2 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-6.36M	USD	2 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	$546.00K	USD	2 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	-	USD	2 Qtrs
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	$18.71M	USD	1 Quarter
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	-	USD	1 Quarter
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	$18.71M	USD	2 Qtrs
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	-	USD	2 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$-501.00K	USD	2 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$113.00K	USD	2 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$383.00K	USD	2 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$324.00K	USD	2 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$2.33M	USD	2 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$9.35M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$586.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$8.70M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$7.03M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.51M	USD	2 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$8.62M	USD	2 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-175.00K	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.71M	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-10.41M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-6.10M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.98M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$155.28M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$149.43M	USD	2 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$43.15M	USD	2 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$12.45M	USD	2 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$13.50M	USD	2 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$27.18M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.24M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.38M	USD	2 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.77M	USD	2 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Investment of forward purchase contract	`InvestmentInUnconsolidatedEntity`	$25.00M	USD	2 Qtrs
Investment of forward purchase contract	`InvestmentInUnconsolidatedEntity`	-	USD	2 Qtrs
Other investing activity	`PaymentsForProceedsFromOtherInvestingActivities`	$556.00K	USD	2 Qtrs
Other investing activity	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.29M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.74M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$24.73M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$25.07M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$32.34M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$56.50M	USD	2 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$41.29M	USD	2 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$50.00M	USD	2 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$125.25M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$109.25M	USD	2 Qtrs
Contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	2 Qtrs
Contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$700.00K	USD	2 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.37M	USD	2 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.25M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-125.01M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-93.06M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.38M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.32M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.75M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$18.90M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$165.53M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$211.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$165.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$211.84M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$11.01M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$15.37M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$7.78M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.14M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.